Bajaj HealthCare Share Price | Bajaj HealthCare Stock Screener
BAJAJHCARE
Pharmaceuticals
Share Price NSE
₹307.05
▲
1.80 (0.59%)
Share Price BSE
₹306.25
▲
3.85 (1.27%)
As of May 27, 2026, the Bajaj HealthCare share price (NSE: BAJAJHCARE) is ₹307.05 on NSE and ₹306.25 on BSE, up 0.59% from the previous close, with shares trading between ₹302.65 and ₹314.90, and a 52-week range of ₹274.95–₹539.70.
Check BAJAJHCARE annual price range for the annual price range and momentum.
Use the Bajaj HealthCare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Bajaj HealthCare Market Cap
₹962.82 Cr.
BAJAJHCARE P/E Ratio (TTM)
65.02
Bajaj HealthCare P/B Ratio
1.92
EPS (TTM)
₹4.98
Dividend Yield
-
Debt to Equity
0.75
BAJAJHCARE 52 Week High
₹539.70
Bajaj HealthCare 52 Week Low
₹274.95
Operating Margin
11.00%
Profit Margin
3.76%
BAJAJHCARE Revenue (TTM)
₹611.00
EBITDA
₹66.00
Net Income
₹23.00
Total Assets
₹923.00
Total Equity
₹533.00
Bajaj HealthCare Share Price Chart
Screen Bajaj HealthCare share price with an interactive chart. Analyse BAJAJHCARE price trends and volatility across different timeframes.
Bajaj HealthCare Company Profile - Fundamental Screener
Screen Bajaj HealthCare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for BAJAJHCARE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE411U01027
Bajaj HealthCare Balance Sheet Screener
Screen BAJAJHCARE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 923 | 833 | 765 | 898 | 721 | 526 | 343 | 283 | 268 | 219 |
| Current Assets | 569 | 485 | 405 | 500 | 398 | 258 | 168 | 124 | 140 | 91 |
| Fixed Assets | 256 | 238 | 253 | 366 | 270 | 208 | 162 | 156 | 127 | 128 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 58 | 95 | 85 | 96 | 71 | 85 | 27 | 19 | 23 | 28 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 533 | 466 | 278 | 368 | 329 | 258 | 178 | 153 | 114 | 99 |
| Share Capital | 17 | 16 | 14 | 14 | 14 | 14 | 14 | 7 | 7 | 7 |
| Reserves & Surplus | 516 | 433 | 265 | 354 | 315 | 245 | 164 | 146 | 107 | 92 |
Bajaj HealthCare Income Statement Screener - Profit & Revenue Analysis
Screen Bajaj HealthCare income statement and profit fundamentals.
Analyze BAJAJHCARE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Bajaj HealthCare share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 611 | 562 | 482 | 647 | 681 | 664 | 417 | 371 | 329 | 233 | 223 | 218 |
| Expenses | 545 | 460 | 397 | 534 | 561 | 521 | 362 | 328 | 288 | 200 | 193 | 190 |
| EBITDA | 66 | 102 | 85 | 113 | 120 | 143 | 55 | 44 | 41 | 33 | 30 | 29 |
| Operating Profit % | 11.00% | 15.00% | 16.00% | 17.00% | 17.00% | 21.00% | 12.00% | 12.00% | 12.00% | 13.00% | 13.00% | 13.00% |
| Depreciation | 28 | 28 | 28 | 17 | 18 | 16 | 12 | 11 | 11 | 11 | 9 | 9 |
| Interest | 22 | 28 | 30 | 18 | 13 | 8 | 6 | 8 | 8 | 8 | 8 | 8 |
| Profit Before Tax | 23 | 46 | -17 | 78 | 90 | 119 | 36 | 24 | 23 | 14 | 14 | 12 |
| Tax | 0 | 3 | -2 | 15 | 18 | 36 | 11 | 8 | 8 | 6 | 5 | 5 |
| Net Profit | 23 | 43 | -14 | 64 | 71 | 83 | 25 | 16 | 15 | 8 | 8 | 8 |
| EPS | 4.98 | 13.29 | -30.36 | 15.59 | 25.87 | 30.11 | 18.29 | 11.82 | 22.01 | 11.37 | 12.15 | 11.13 |
Bajaj HealthCare Cash Flow Screener - Liquidity Fundamentals
Screen BAJAJHCARE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 22 | 92 | -22 | 1 | 44 | 21 | 25 | 17 | 22 | 25 |
| Investing Activities | -15 | -11 | -93 | -75 | -109 | -28 | -13 | -12 | -8 | -31 |
| Financing Activities | -6 | -97 | 131 | 62 | 76 | 3 | -13 | 3 | -13 | 5 |
| Net Cash Flow | 0 | -16 | 16 | -12 | 10 | -4 | 0 | 7 | 1 | 0 |
Bajaj HealthCare Shareholding Pattern Screener
See Bajaj HealthCare shareholding pattern with promoter, FII, and DII holdings.
Check Bajaj HealthCare promoter holding and ownership changes for BAJAJHCARE on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 58.29% | 59.19% | 59.19% | 59.19% | 59.19% | 67.73% | 67.73% | 59.19% |
| FII Holding | 1.98% | 1.05% | 1.09% | 1.12% | 1.18% | 0.53% | 0.01% | 1.07% |
| DII Holding | 2.91% | 2.52% | 3.16% | 3.00% | 2.96% | 0.44% | 0.00% | 1.97% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 28.49% | 26.72% | 26.63% | 26.24% | 26.62% | 19.91% | 20.17% | 25.52% |
| Other Holding | 8.33% | 10.52% | 9.93% | 10.45% | 10.05% | 11.39% | 12.09% | 12.26% |
| Shareholder Count | 37,696 | 35,710 | 35,980 | 38,574 | 37,951 | 32,712 | 32,397 | 31,993 |
Bajaj HealthCare Share Dividend Screener - Share Yield Analysis
Check Bajaj HealthCare dividend history with payout and yield data.
View Bajaj HealthCare dividend details including ex-dates and amounts for BAJAJHCARE stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹1.00 | 0.34% |
| 2024-March | ₹1.00 | 0.15% |
| 2023-March | ₹1.00 | 0.34% |
| 2022-March | ₹1.50 | 0.52% |
| 2021-March | ₹2.75 | 0.81% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Bajaj HealthCare Stock Index Membership
See which indices include Bajaj HealthCare stock.
Check BAJAJHCARE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Bajaj HealthCare Market Events Screener - Corporate Actions
Get Bajaj HealthCare corporate actions including splits, bonuses, and buybacks.
Check Bajaj HealthCare stock events that may affect BAJAJHCARE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 15.00% | ||
| Dividend | ₹ 0.50 /share | 16.12% | ||
| Dividend | ₹ 0.50 /share | 16.12% | ||
| Dividend | ₹ 1.50 /share | 19.71% | ||
| Dividend | ₹ 1.00 /share | 52.98% | ||
| Annual General Meeting | NA | 25.91% | ||
| Dividend | ₹ 1.00 /share | 28.33% | ||
| Annual General Meeting | NA | -0.10% | ||
| Dividend | ₹ 1.00 /share | -26.31% | ||
| 2026-05-08 | 2026-05-08 | Quarterly Result Announcement | NA | 5.56% |
| 2026-01-16 | 2026-01-16 | Quarterly Result Announcement | NA | -0.57% |
| 2025-10-17 | 2025-10-17 | Quarterly Result Announcement | NA | 2.25% |
| 2025-07-28 | 2025-07-28 | Quarterly Result Announcement | NA | -0.62% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | 1.77% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | -5.60% |
Bajaj HealthCare Competitors Screener - Peer Comparison
Screen BAJAJHCARE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 439,246 | 40.42 | 58,220 | 6.38% | 11,565 | 54.03 |
| Divis Laboratories | 178,713 | 73.73 | 10,560 | 8.73% | 2,520 | 57.30 |
| Torrent Pharmaceuticals | 149,728 | 66.80 | 13,753 | 19.18% | 2,028 | 66.36 |
| Cipla | 114,398 | 29.26 | 27,712 | -2.46% | 3,783 | 64.19 |
| Dr Reddys Laboratories | 111,341 | 26.24 | 33,593 | -0.44% | 3,998 | 57.44 |
| Zydus Life Science | 108,452 | 20.40 | 26,720 | 13.65% | 5,242 | 73.90 |
| Lupin | 103,068 | 19.46 | 27,488 | 19.98% | 5,345 | 48.15 |
| Mankind Pharma | 100,147 | 52.84 | 14,278 | 12.03% | 1,750 | 59.66 |
| Aurobindo Pharma | 84,501 | 24.29 | 33,385 | 3.21% | 3,376 | 51.11 |
| Laurus Labs | 73,879 | 81.46 | 6,813 | 21.03% | 884 | 78.36 |
Bajaj HealthCare Company Announcements - News Screener
Screen BAJAJHCARE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-05-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-08 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-08 | Compliances-Statement Of Deviation & Variation | - |
| 2026-05-08 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-05-08 | Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 | - |
| 2026-05-08 | Announcement under Regulation 30 (LODR)-Dividend Updates | - |
| 2026-05-08 | Results- Financial Results For 31/03/2026 | - |
| 2026-05-08 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 08Th May 2026 | - |
| 2026-05-07 | Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 | - |
| 2026-05-02 | Board Meeting Intimation for Consideration Of Financial Results | - |
| 2026-04-24 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-24 | Closure of Trading Window | - |
| 2026-03-20 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-20 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-19 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-18 | Board Meeting Outcome for Allotment Of Equity Shares Pursuant To Conversion Of Convertible Warrants Into Equity Shares | - |
| 2026-03-17 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-17 | Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 | - |
| 2026-03-16 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |